» Articles » PMID: 34225730

Anti-cancer Properties of Quercetin in Osteosarcoma

Overview
Journal Cancer Cell Int
Publisher Biomed Central
Date 2021 Jul 6
PMID 34225730
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Osteosarcoma is a primary bone tumor. Although it is a rare disease in general, it is the most common primary bone tumor among children. Despite the significant advances made in the field of osteosarcoma treatment, the outcomes of this disease are still unfavorable. Besides, there is still no targeted therapy for osteosarcoma that can be used in clinical settings. Quercetin is a member of the phytochemical family which is used for different diseases including cardiovascular diseases, diabetes, and cancer. Its anti-cancer effects are examined in many types of cancer including breast, colon, lung, prostate, and pancreatic cancers and have shown promising results. Herein, the studies dealing with the antitumor roles of quercetin in osteosarcoma are reviewed in this article. We take a look into quercetin's ability to affect proliferation, apoptosis, invasion, and chemo-resistance of the osteosarcoma cells through regulating protein expression and signaling pathways.

Citing Articles

Prominent Naturally Derived Oxidative-Stress-Targeting Drugs and Their Applications in Cancer Treatment.

Lee E, Yang D, Hong J Antioxidants (Basel). 2025; 14(1).

PMID: 39857383 PMC: 11760868. DOI: 10.3390/antiox14010049.


The M1/M2 Macrophage Polarization and Hepatoprotective Activity of Quercetin in Cyclophosphamide-Induced Experimental Liver Toxicity.

Seker U, Uyar E, Gokdemir G, Kavak D, Irtegun-Kandemir S Vet Med Sci. 2025; 11(1):e70183.

PMID: 39792066 PMC: 11720735. DOI: 10.1002/vms3.70183.


3D printed scaffolds with quercetin and vitamin D3 nanocarriers: In vitro cellular evaluation.

Bose S, Chaudhari V, Kushram P J Biomed Mater Res A. 2024; 112(12):2110-2123.

PMID: 38894584 PMC: 11464199. DOI: 10.1002/jbm.a.37756.


Correlation of High-Grade Osteosarcoma Response to Chemotherapy with Enhanced Tissue Immunological Response: Analysis of CD95R, IFN-γ, Catalase, Hsp70, and VEGF.

Mustokoweni S, Mahyudin F, Setiawati R, Nugrahenny D, Hidayat M, Kalim H Virchows Arch. 2024; 484(6):925-937.

PMID: 38748263 PMC: 11186924. DOI: 10.1007/s00428-024-03801-z.


Extrusion 3D-printed tricalcium phosphate-polycaprolactone biocomposites for quercetin-KCl delivery in bone tissue engineering.

Toulou C, Chaudhari V, Bose S J Biomed Mater Res A. 2024; 112(9):1472-1483.

PMID: 38477071 PMC: 11239310. DOI: 10.1002/jbm.a.37692.


References
1.
Alban L, Monteiro W, Diz F, Miranda G, Scheid C, Zotti E . New quercetin-coated titanate nanotubes and their radiosensitization effect on human bladder cancer. Mater Sci Eng C Mater Biol Appl. 2020; 110:110662. DOI: 10.1016/j.msec.2020.110662. View

2.
Hussain Y, Mirzaei S, Ashrafizadeh M, Zarrabi A, Hushmandi K, Khan H . Quercetin and Its Nano-Scale Delivery Systems in Prostate Cancer Therapy: Paving the Way for Cancer Elimination and Reversing Chemoresistance. Cancers (Basel). 2021; 13(7). PMC: 8036441. DOI: 10.3390/cancers13071602. View

3.
Chen S, Jiang H, Wu X, Fang J . Therapeutic Effects of Quercetin on Inflammation, Obesity, and Type 2 Diabetes. Mediators Inflamm. 2016; 2016:9340637. PMC: 5149671. DOI: 10.1155/2016/9340637. View

4.
Thomasset S, Berry D, Garcea G, Marczylo T, Steward W, Gescher A . Dietary polyphenolic phytochemicals--promising cancer chemopreventive agents in humans? A review of their clinical properties. Int J Cancer. 2006; 120(3):451-8. DOI: 10.1002/ijc.22419. View

5.
Worth L, LaFleur E, Jia S, Kleinerman E . Fas expression inversely correlates with metastatic potential in osteosarcoma cells. Oncol Rep. 2002; 9(4):823-7. View